
Jeplus.in
Purchase All Medicines.Get 10% Offer

Pharma Tech
Joining a minimalistic wave in pharma marketing, Novo said the change increases memorability and relevance.

Pharma Tech
Share prices tumbled last week after a key asset from Novartis’ $12bn Avidity deal fumbled in a Phase III trial.

Pharma Tech
GlobalData analysts predicts that myostatin inhibitors like Isemblyd will be key drivers of growth within the SMA market in years to come.

Pharma Tech
Cell and gene therapies are fuelling new possibilities for rare diseases, turning a field defined by unmet need into one of the industry’s most dynamic areas of innovation.

PharmaShots
Shots: 20. Vyndaqel Family Non-Proprietary Name: Tafamidis Company: Pfizer First Approved: US (Nov 13, 2015), EU (Feb 1, 2016) Total Revenue: $6.38B 19. Prevnar Family Non-Proprietary Name: Pneumococcal Conjugate Vaccines Company: Pfizer First Approved: US (Nov 13, 2015), EU (Feb 1, 2016) Total Revenue: $6.49B 18. Cosentyx Non-Proprietary Name: Upadacitinib Company: Novartis First Approved: US (Jan… The post Top 20 Prescription Drugs of 2026 appeared first on PharmaShots.
Sponsored content

Purchase All Medicines.Get 10% Offer
News
Pharma Tech
Sep 14, 2026, 2:52 PM
Joining a minimalistic wave in pharma marketing, Novo said the change increases memorability and relevance.
ET Pharma
Sep 14, 2026, 12:57 PM
DengiAll, India’s first indigenous, single-dose, dengue vaccine is expected to work against all four strains of dengue prevalent in the country.
ET Pharma
Sep 14, 2026, 12:52 PM
The South San Francisco, California-based company is seeking to raise as much as $346.7 million by offering about 21.67 million shares priced between $14 and $16 apiece.
PharmaShots
Sep 14, 2026, 12:30 PM
Shots: Ref: Cyllene | Image: Cyllene | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Cyllene Therapeutics Secures US FDA RMAT Designation for EG110A in Neurogenic Detrusor Overactivity appeared first on PharmaShots.
PharmaShots
Sep 14, 2026, 11:30 AM
Shots: Ref: Businesswire | Image: Takeda | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post The US FDA Grants Priority Review to Takeda’s Zasocitinib in Plaque Psoriasis appeared first on PharmaShots.
Pharma Tech
Sep 14, 2026, 10:39 AM
Share prices tumbled last week after a key asset from Novartis’ $12bn Avidity deal fumbled in a Phase III trial.
News
Google News
Sep 14, 2026, 5:28 PM
Evonik Breaks Ground on New Biotechnology Expansion Project in Slovakia Contract Pharma
Google News
Sep 14, 2026, 5:16 PM
Wendy Short Bartie Integrates Patient Advocacy and Public Trust into Bristol Myers Squibb Business Strategy geneonline.com
Google News
Sep 14, 2026, 4:29 PM
Vyome Welcomes Jerry Leonard as New Chief Financial Officer Contract Pharma
Google News
Sep 14, 2026, 4:29 PM
Egypt, India seek to boost health co-operation egyptian-gazette.com
Google News
Sep 14, 2026, 4:27 PM
FactCheck: Four claims made by Donald Trump during his trip to Ireland thejournal.ie
Google News
Sep 14, 2026, 4:08 PM
Syntegon Opens OSD Customer Center in Fellbach Contract Pharma
Google News
Sep 14, 2026, 3:51 PM
Extracting CBD: from artisanal practice to industrial production Lampoon Magazine
Google News
Sep 14, 2026, 3:45 PM
Symbiosis Names Jos Vergeest Senior Business Development Director Contract Pharma
Google News
Sep 14, 2026, 3:22 PM
No more Nordisk: Novo’s latest trim is in its name Pharmaceutical Technology
Sponsored placement

Purchase All Medicines.Get 10% Offer